InCarda Therapeutics
incardatherapeutics.com
Actively hiring
Exhibitions
Hospitals & Health Systems
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$63.3M
3 rounds on record
Latest round
$28M
Venture round · Oct 2020 · 5 yr ago
Team
51-200
employees, estimated range
Backers
2
HealthCap, Sofinnova Investments
The money's age
Long since its last round
71 months since the last round · not hiring
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 8%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2020 | $28M | — | SEC Form D |
| Venture round | Oct 2017 | $35.3M | — | SEC Form D |
| Debt Financing | Mar 2017 | $2.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | InCarda Therapeutics, Inc. | sec |
Founders and leadersfrom filings, registers and the company's site
Rangachari NarasimhanExecutive Officer, DirectorSEC Form D
Grace ColonExecutive Officer, DirectorSEC Form D
Miller SamanthaExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
HealthCap 
Sofinnova Investments Similar startupsby what they do, their industry and backers
Kintsugi is developing novel voice biomarker infrastructure to detect signs of depression and anxiety from short clips of free form speech…
We provide clinical pharmacist-reviewed, AI-generated drug information, so your clinical pharmacists can spend more time with patients.
Our people take the time to get to know you, your family, and your business. Get to know us and you’ll see that you belong at Union Bank &…
The only FDA-cleared device to deviate the esophagus and reduce the risk of thermal injury during ablation for atrial fibrillation.
Win and keep more patients with Upfront by Health Catalyst's patient engagement suite - powered by consumer science.
Stem is an industry changing approach to how clothing is made. Our novel zero-waste woven textile system eliminates garment production…
Overview
Developing novel treatments for patients with atrial fibrillation. We are developing drugs designed to safety, effectively, and quickly get patients back to where they belong - in normal sinus rhythm.
People
Rangachari Narasimhan
Executive Officer, Director
Grace Colon
Executive Officer, Director
Miller Samantha
Executive Officer
McCarthy Reenie
Director
Bischofberger Norbert
Director
Isaac Cheng
Director
Alan Colowick
Director
Johan Christenson
Director
Andrew ElBardissi
Director
Dan Welch
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Newark
United States
HQ
50-200 est. staff